Skip to main content
Clinical Trials/NCT02722720
NCT02722720
Completed
Not Applicable

Prospective, Randomized, Single Center Study of Atherothrombotic and Thromboembolic Events After Carotid Artery Stenting Using Transfemoral and Transradial Approach

Meshalkin Research Institute of Pathology of Circulation1 site in 1 country200 target enrollmentSeptember 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Carotid Atherosclerosis
Sponsor
Meshalkin Research Institute of Pathology of Circulation
Enrollment
200
Locations
1
Primary Endpoint
Cerebral embolism
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The aim is to compare the safety of using transfemoral and transradial approach in patient undergoing carotid arteries stenting.

Detailed Description

The use of transradial approach in carotid arteries stenting can significantly decrease the amount of adverse events associated with transfemoral approach such as bleeding or hematoma. Otherwise providing transradial approach is fraught with technical difficulties of common carotid artery canulation that can result in embolic complications. Taking into account the absence of studies in this area of medicine, providing investigation evaluating parameters of safety for both methodics is very actual.

Registry
clinicaltrials.gov
Start Date
September 2015
End Date
December 2016
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Meshalkin Research Institute of Pathology of Circulation
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Symptomatic patients with internal carotid artery stenosis(\>50%)
  • Asymptomatic patients with internal carotid artery stenosis(\>60%)
  • Anatomy of internal carotid artery applicable for stent implantation and use of embolic protection device

Exclusion Criteria

  • Stroke, myocardial infarction or underwent operative treatment within 1 month
  • Prior carotid artery stenting
  • Cerebral vessels aneurisms/ malformations
  • Subclavian artery/ brachiocephalic trunk stenosis
  • Contraindications for antiplatelet or/and anticoagulation therapy

Outcomes

Primary Outcomes

Cerebral embolism

Time Frame: during 24 hours after carotid artery stenting

Amount of intraoperative micro- and macroembolic complications evaluated as an occurence of new ipsilateral ischemic lesions estimated due to brain MRI data.

Secondary Outcomes

  • Neurocognitive disorders(before and 30 days after carotid artery stenting)
  • Device success(intraoperative)
  • Lesion success(intraoperative)
  • Cerebral embolism(intraoperative)
  • MACCE(during 30 days after carotid artery stenting)
  • Operative access complications(intraoperative/ 1 day after operation)
  • Fluoroscopic time(intraoperative)
  • In-hospital procedure success(Within 5-day hospitalization)

Study Sites (1)

Loading locations...

Similar Trials